It is unclear from our current study, which, if any of these effects, were direct results of reduced P2Y2 signaling in metabolic tissues, e.g., adipose or liver, or rather than general effects of reduced obesity and inflammatory sequelae. This evidence concerns the gene P2RY2 and obesity disorder.